Unyvero A50 System – Molecular Diagnostic Platform

Fast & Simple Syndromic Testing for Severe Infections – Improving Patient Outcomes

The Unyvero A50 System is a syndromic testing platform for fast diagnosis of severe infectious diseases. The system uses powerful multiplex PCR technology to detect a wide variety of microorganisms and antibiotic resistance markers within 4-5 hours

Under 2 minutes hands-on time, 4-5 hours to results, simple-automated, direct from specimen, detect microorganisms & antibiotic resistance markers

  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Fungi
  • Viruses
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Marketed product
  • Research
  • Development
  • Validation
  • Market entry

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Joint Venture
  • Sell
  • Outsource

Funding organisation:

    Infectious disease area:

      Geographic origin:

        Companies looking for a multiplex PCR platform, AMR data intelligence for diagnostics

        Curetis N.V.’s goal is to become a leading provider of innovative solutions for molecular diagnostics platforms combining with AMR data intelligence.

        Curetis’ subsidiary Ares Genetics GmbH offers next-generation solutions for infectious disease diagnostics. The ARESdb Platform one of the most comprehensive databases worldwide on genetics of antimicrobial resistances with advanced bioinformatics

        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!